40.50
2.48%
-1.03
Ideaya Biosciences Inc Borsa (IDYA) Ultime notizie
BNP Paribas Financial Markets Buys 155,179 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat
MarketBeat
BNP Paribas Financial Markets Acquires 155179 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World
Defense World
RBC Capital Maintains Ideaya Biosciences (IDYA) Outperform Recommendation - MSN
MSN
Oppenheimer Maintains Ideaya Biosciences (IDYA) Outperform Recommendation - MSN
MSN
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) CEO Sells $1,439,643.73 in Stock - MarketBeat
MarketBeat
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Short Interest Update - Defense World
Defense World
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Short Interest Update - MarketBeat
MarketBeat
Nicholas Investment Partners LP Invests $3.93 Million in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat
MarketBeat
The Goldman Sachs Group Lowers IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $46.00 - Defense World
Defense World
The Goldman Sachs Group Lowers IDEAYA Biosciences (NASDAQ:IDYA) Price Target to $46.00 - MarketBeat
MarketBeat
How Many IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Do Institutions Own? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
Victory Capital Management Inc. Acquires Shares of 346,490 IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat
MarketBeat
(IDYA) Investment Report - Stock Traders Daily
Stock Traders Daily
IDEAYA Biosciences (IDYA) Stock Forecast and Price Target 2024 - MarketBeat
MarketBeat
Q2 2024 Earnings Estimate for IDEAYA Biosciences, Inc. Issued By Wedbush (NASDAQ:IDYA) - Defense World
Defense World
Q2 2024 EPS Estimates for IDEAYA Biosciences, Inc. Decreased by Analyst (NASDAQ:IDYA) - MarketBeat
MarketBeat
New York State Common Retirement Fund Buys 20,185 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat
MarketBeat
New York State Common Retirement Fund Boosts Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World
Defense World
Q1 2025 Earnings Estimate for IDEAYA Biosciences, Inc. Issued By Wedbush (NASDAQ:IDYA) - Defense World
Defense World
New York State Common Retirement Fund Buys 20,185 Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat
MarketBeat
Brokers Issue Forecasts for IDEAYA Biosciences, Inc.'s Q1 2025 Earnings (NASDAQ:IDYA) - MarketBeat
MarketBeat
IDEAYA Biosciences (NASDAQ:IDYA) Announces Quarterly Earnings Results - MarketBeat
MarketBeat
Wedbush Reaffirms "Outperform" Rating for IDEAYA Biosciences (NASDAQ:IDYA) - MarketBeat
MarketBeat
IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Singapore News
Yahoo Singapore News
Unveiling 5 Analyst Insights On IDEAYA Biosciences - IDEAYA Biosciences (NASDAQ:IDYA) - Benzinga
Benzinga
Ideaya Biosciences reports Q1 EPS (53c), consensus (51c) - TipRanks.com - TipRanks
TipRanks
IDEAYA Biosciences First Quarter 2024 Earnings: US$0.53 loss per share (vs US$0.49 loss in 1Q 2023) - Yahoo Finance
Yahoo Finance
Wedbush Reaffirms "Outperform" Rating for IDEAYA Biosciences (NASDAQ:IDYA) - MarketBeat
MarketBeat
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update - PR Newswire
PR Newswire
IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Tops Revenue Estimates - Yahoo New Zealand News
Yahoo New Zealand News
Fisher Asset Management LLC Boosts Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World
Defense World
IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo New Zealand News
Yahoo New Zealand News
How the (IDYA) price action is used to our Advantage - Stock Traders Daily
Stock Traders Daily
IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event - Investing.com South Africa
Investing.com South Africa
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - PR Newswire
PR Newswire
IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma ... - Financial Times
Financial Times
IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma ... - PR Newswire
PR Newswire
IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in ... - PR Newswire
PR Newswire
Ideaya Biosciences announces inducement grants under Nasdaq listing rule - TipRanks.com - TipRanks
TipRanks
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Investing.com India
Investing.com India
IDEAYA and Merck enter collaboration for endometrial cancer trial - Clinical Trials Arena
Clinical Trials Arena
IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in ... - PR Newswire
PR Newswire
Demystifying IDEAYA Biosciences: Insights From 6 Analyst Reviews
Benzinga
IDYA Stock Quote Price and Forecast - CNN
CNN
IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events - BioSpace
BioSpace
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance
Yahoo Finance
Is IDEAYA Biosciences (NASDAQ:IDYA) A Risky Investment? - Simply Wall St
Simply Wall St
The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 6 Experts
Benzinga
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update - Yahoo Finance
Yahoo Finance
IDEAYA Biosciences: A Strong Bet In Targeted Oncology (NASDAQ:IDYA) - Seeking Alpha
Seeking Alpha
Capitalizzazione:
|
Volume (24 ore):